ERBB2 and breast cancer: PID has been used for HER2 detection in BC, Colony Stimulating Factor 1 Receptor (CSF1R) detection in tumor-associated macrophages [23], quantitative detection of Estrogen receptor alpha (ERα) [24], and intratumoral pharmacokinetics of new HER2-targeted ADC [25].